Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs KraneShares CSI China Internet ETF (KWEB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs KraneShares CSI China Internet ETF — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.45 (market cap $6.04B), while KraneShares CSI China Internet ETF trades at $24.86 (market cap $4.37B). The key difference: Iovance Biotherapeutics Inc. Common Stock is the larger of the two by market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, KraneShares CSI China Internet ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and KraneShares CSI China Internet ETF for 57 Days on average.
| IOVA | KWEB | |
|---|---|---|
Market Cap | $6.04B | $4.37B |
Volume | 14,805,993 | 13,393,361 |
Sector | Health | Sector/Thematic |
52-Week High | $14.82 | $41.35 |
52-Week Low | $1.81 | $23.63 |
Typical Hold Time | 0 Days | 57 Days |
Enterprise Value | $5.97B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
KWEB trades at $24.87, up 2.22% with bearish technical signals from moving averages and neutral oscillators. Recent news highlights institutional position changes and China-focused economic developments. The ETF faces headwinds from U.S.-China trade dynamics and Chinese industrial overcapacity concerns.
The outlook remains cautious due to geopolitical risks and technical weakness. Investment opportunities exist for those bullish on China's internet sector recovery, but risks include trade tensions and economic rebalancing pressures that could impact performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About KraneShares CSI China Internet ETF
KWEB tracks the CSI Overseas China Internet Index, providing exposure to Chinese software and services companies listed in the US and Hong Kong, including giants like Tencent, Alibaba, and Meituan.
Read more on KWEB →
